Global Gene Therapies for Tumor Treatment Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

This in-depth market research offers all the details related to the growth potential of the Gene Therapies for Tumor Treatment Market, which can help interested party get a clear picture about the present and future key trends and prospects of the Gene Therapies for Tumor Treatment market. Furthermore, the report incorporates the information regarding the growth opportunities & challenges and competitive scenarios of the market on the global scale. The report provides all the necessary information using primary and secondary sources coupled with variety of tools. The market analysis provided in the report provides a panoramic view of the market growth potential and better understanding of the future market scope and opportunities. The report touches upon the vital factors such as market size and market growth rate after analyzing the market even during the COVID-19 outbreak.

Data provided by Extent Research. Source: https://www.extentresearch.com/gene-therapies-for-tumor-treatment-market

The virus outbreak is found to have brought about a dynamic change in the industry and the entire economic condition. This report also covers the analysis of the influence of the COVID-19 pandemic on market dynamic and revenue. In addition to this, all the present and future aspects of the Gene Therapies for Tumor Treatment market is penciled down after thorough market analysis. Moreover, the segmentation of the market by Product type Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, , by Application Hospital, Clinic, Other, , company profiles of Novartis, Kite Pharma, Amgen, Shanghai Sunway, Sibiono, , types, and others is anticipated to help understand the product position and market popularity in the forecast years.

The comprehensive research report covers all the historical data and forecast estimation as well. Thereby, the extensive Gene Therapies for Tumor Treatment market analysis on the regional and competitive landscape gives a brief idea about the product development, sales, demand & supply trends, regional market share, and size. The research report offered by Extent Research offers an up-to-date insight of the Gene Therapies for Tumor Treatment market. The emerging drivers and trends of the market that are projected to influence the industry growth are also mentioned in the report. Speaking of Gene Therapies for Tumor Treatment market report, it covers all the market size & growth, market dynamics, opportunities & challenges, competitive landscape, and regional breakdown.

Report Scope and Market Segmentation

ATTRIBUTES	Global Gene Therapies for Tumor Treatment Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Gene Therapies for Tumor Treatment Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Gene Therapies for Tumor Treatment Product Introduction
    1.2 Market by Type
        1.2.1 Global Gene Therapies for Tumor Treatment Market Size by Type, 2017 VS 2021 VS 2035
        1.2.2 Gene Induced Immunotherapy
        1.2.3 Oncolytic Virotherapy
        1.2.4 Gene Transfer
    1.3 Market by Application
        1.3.1 Global Gene Therapies for Tumor Treatment Market Size by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Gene Therapies for Tumor Treatment Production
    2.1 Global Gene Therapies for Tumor Treatment Production Capacity (2017-2035)
    2.2 Global Gene Therapies for Tumor Treatment Production by Region: 2017 VS 2021 VS 2035
    2.3 Global Gene Therapies for Tumor Treatment Production by Region
        2.3.1 Global Gene Therapies for Tumor Treatment Historic Production by Region (2017-2022)
        2.3.2 Global Gene Therapies for Tumor Treatment Forecasted Production by Region (2023-2035)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Gene Therapies for Tumor Treatment Sales in Volume & Value Estimates and Forecasts
    3.1 Global Gene Therapies for Tumor Treatment Sales Estimates and Forecasts 2017-2035
    3.2 Global Gene Therapies for Tumor Treatment Revenue Estimates and Forecasts 2017-2035
    3.3 Global Gene Therapies for Tumor Treatment Revenue by Region: 2017 VS 2021 VS 2035
    3.4 Global Gene Therapies for Tumor Treatment Sales by Region
        3.4.1 Global Gene Therapies for Tumor Treatment Sales by Region (2017-2022)
        3.4.2 Global Sales Gene Therapies for Tumor Treatment by Region (2023-2035)
    3.5 Global Gene Therapies for Tumor Treatment Revenue by Region
        3.5.1 Global Gene Therapies for Tumor Treatment Revenue by Region (2017-2022)
        3.5.2 Global Gene Therapies for Tumor Treatment Revenue by Region (2023-2035)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Gene Therapies for Tumor Treatment Production Capacity by Manufacturers
    4.2 Global Gene Therapies for Tumor Treatment Sales by Manufacturers
        4.2.1 Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2017-2022)
        4.2.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Gene Therapies for Tumor Treatment in 2021
    4.3 Global Gene Therapies for Tumor Treatment Revenue by Manufacturers
        4.3.1 Global Gene Therapies for Tumor Treatment Revenue by Manufacturers (2017-2022)
        4.3.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2021
    4.4 Global Gene Therapies for Tumor Treatment Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Gene Therapies for Tumor Treatment Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Gene Therapies for Tumor Treatment Sales by Type
        5.1.1 Global Gene Therapies for Tumor Treatment Historical Sales by Type (2017-2022)
        5.1.2 Global Gene Therapies for Tumor Treatment Forecasted Sales by Type (2023-2035)
        5.1.3 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2035)
    5.2 Global Gene Therapies for Tumor Treatment Revenue by Type
        5.2.1 Global Gene Therapies for Tumor Treatment Historical Revenue by Type (2017-2022)
        5.2.2 Global Gene Therapies for Tumor Treatment Forecasted Revenue by Type (2023-2035)
        5.2.3 Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2035)
    5.3 Global Gene Therapies for Tumor Treatment Price by Type
        5.3.1 Global Gene Therapies for Tumor Treatment Price by Type (2017-2022)
        5.3.2 Global Gene Therapies for Tumor Treatment Price Forecast by Type (2023-2035)
6 Market Size by Application
    6.1 Global Gene Therapies for Tumor Treatment Sales by Application
        6.1.1 Global Gene Therapies for Tumor Treatment Historical Sales by Application (2017-2022)
        6.1.2 Global Gene Therapies for Tumor Treatment Forecasted Sales by Application (2023-2035)
        6.1.3 Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2035)
    6.2 Global Gene Therapies for Tumor Treatment Revenue by Application
        6.2.1 Global Gene Therapies for Tumor Treatment Historical Revenue by Application (2017-2022)
        6.2.2 Global Gene Therapies for Tumor Treatment Forecasted Revenue by Application (2023-2035)
        6.2.3 Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2035)
    6.3 Global Gene Therapies for Tumor Treatment Price by Application
        6.3.1 Global Gene Therapies for Tumor Treatment Price by Application (2017-2022)
        6.3.2 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2023-2035)
7 North America
    7.1 North America Gene Therapies for Tumor Treatment Market Size by Type
        7.1.1 North America Gene Therapies for Tumor Treatment Sales by Type (2017-2035)
        7.1.2 North America Gene Therapies for Tumor Treatment Revenue by Type (2017-2035)
    7.2 North America Gene Therapies for Tumor Treatment Market Size by Application
        7.2.1 North America Gene Therapies for Tumor Treatment Sales by Application (2017-2035)
        7.2.2 North America Gene Therapies for Tumor Treatment Revenue by Application (2017-2035)
    7.3 North America Gene Therapies for Tumor Treatment Sales by Country
        7.3.1 North America Gene Therapies for Tumor Treatment Sales by Country (2017-2035)
        7.3.2 North America Gene Therapies for Tumor Treatment Revenue by Country (2017-2035)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Gene Therapies for Tumor Treatment Market Size by Type
        8.1.1 Europe Gene Therapies for Tumor Treatment Sales by Type (2017-2035)
        8.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Type (2017-2035)
    8.2 Europe Gene Therapies for Tumor Treatment Market Size by Application
        8.2.1 Europe Gene Therapies for Tumor Treatment Sales by Application (2017-2035)
        8.2.2 Europe Gene Therapies for Tumor Treatment Revenue by Application (2017-2035)
    8.3 Europe Gene Therapies for Tumor Treatment Sales by Country
        8.3.1 Europe Gene Therapies for Tumor Treatment Sales by Country (2017-2035)
        8.3.2 Europe Gene Therapies for Tumor Treatment Revenue by Country (2017-2035)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Gene Therapies for Tumor Treatment Market Size by Type
        9.1.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2017-2035)
        9.1.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Type (2017-2035)
    9.2 Asia Pacific Gene Therapies for Tumor Treatment Market Size by Application
        9.2.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2017-2035)
        9.2.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Application (2017-2035)
    9.3 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
        9.3.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2017-2035)
        9.3.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2017-2035)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Gene Therapies for Tumor Treatment Market Size by Type
        10.1.1 Latin America Gene Therapies for Tumor Treatment Sales by Type (2017-2035)
        10.1.2 Latin America Gene Therapies for Tumor Treatment Revenue by Type (2017-2035)
    10.2 Latin America Gene Therapies for Tumor Treatment Market Size by Application
        10.2.1 Latin America Gene Therapies for Tumor Treatment Sales by Application (2017-2035)
        10.2.2 Latin America Gene Therapies for Tumor Treatment Revenue by Application (2017-2035)
    10.3 Latin America Gene Therapies for Tumor Treatment Sales by Country
        10.3.1 Latin America Gene Therapies for Tumor Treatment Sales by Country (2017-2035)
        10.3.2 Latin America Gene Therapies for Tumor Treatment Revenue by Country (2017-2035)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Gene Therapies for Tumor Treatment Market Size by Type
        11.1.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2017-2035)
        11.1.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Type (2017-2035)
    11.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Size by Application
        11.2.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2017-2035)
        11.2.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Application (2017-2035)
    11.3 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country
        11.3.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2017-2035)
        11.3.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2017-2035)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 U.A.E
12 Corporate Profiles
    12.1 Novartis
        12.1.1 Novartis Corporation Information
        12.1.2 Novartis Overview
        12.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Novartis Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Novartis Recent Developments
    12.2 Kite Pharma
        12.2.1 Kite Pharma Corporation Information
        12.2.2 Kite Pharma Overview
        12.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Kite Pharma Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Kite Pharma Recent Developments
    12.3 Amgen
        12.3.1 Amgen Corporation Information
        12.3.2 Amgen Overview
        12.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Amgen Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Amgen Recent Developments
    12.4 Shanghai Sunway
        12.4.1 Shanghai Sunway Corporation Information
        12.4.2 Shanghai Sunway Overview
        12.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Shanghai Sunway Recent Developments
    12.5 Sibiono
        12.5.1 Sibiono Corporation Information
        12.5.2 Sibiono Overview
        12.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Sibiono Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Sibiono Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Gene Therapies for Tumor Treatment Industry Chain Analysis
    13.2 Gene Therapies for Tumor Treatment Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Gene Therapies for Tumor Treatment Production Mode & Process
    13.4 Gene Therapies for Tumor Treatment Sales and Marketing
        13.4.1 Gene Therapies for Tumor Treatment Sales Channels
        13.4.2 Gene Therapies for Tumor Treatment Distributors
    13.5 Gene Therapies for Tumor Treatment Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Gene Therapies for Tumor Treatment Industry Trends
    14.2 Gene Therapies for Tumor Treatment Market Drivers
    14.3 Gene Therapies for Tumor Treatment Market Challenges
    14.4 Gene Therapies for Tumor Treatment Market Restraints
15 Key Finding in The Global Gene Therapies for Tumor Treatment Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Gene Therapies for Tumor Treatment Market